id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_5600
split_0_train_5600
[ { "id": "split_0_train_5600_passage", "type": "progene_text", "text": [ "Human CAP1 is a key factor in the recycling of cofilin and actin for rapid actin turnover ." ], "offsets": [ [ 0, 91 ] ] } ]
[ { "id": "split_0_train_8581_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 6, 10 ] ], "normalized": [] }, { "id": "split_0_train_8582_entity", "type": "progene_text", "text": [ "cofilin" ], "offsets": [ [ 47, 54 ] ], "normalized": [] }, { "id": "split_0_train_8583_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 59, 64 ] ], "normalized": [] }, { "id": "split_0_train_8584_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 75, 80 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5601
split_0_train_5601
[ { "id": "split_0_train_5601_passage", "type": "progene_text", "text": [ "Cofilin - ADF ( actin - depolymerizing factor ) is an essential driver of actin - based motility ." ], "offsets": [ [ 0, 98 ] ] } ]
[ { "id": "split_0_train_8585_entity", "type": "progene_text", "text": [ "Cofilin" ], "offsets": [ [ 0, 7 ] ], "normalized": [] }, { "id": "split_0_train_8586_entity", "type": "progene_text", "text": [ "ADF" ], "offsets": [ [ 10, 13 ] ], "normalized": [] }, { "id": "split_0_train_8587_entity", "type": "progene_text", "text": [ "actin - depolymerizing factor" ], "offsets": [ [ 16, 45 ] ], "normalized": [] }, { "id": "split_0_train_8588_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 74, 79 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5602
split_0_train_5602
[ { "id": "split_0_train_5602_passage", "type": "progene_text", "text": [ "We discovered two proteins , p65 and p55 , that are components of the actin - cofilin complex in a human HEK293 cell extract and identified p55 as CAP1 / ASP56 , a human homologue of yeast CAP / SRV2 ( cyclase - associated protein ) ." ], "offsets": [ [ 0, 234 ] ] } ]
[ { "id": "split_0_train_8589_entity", "type": "progene_text", "text": [ "p65" ], "offsets": [ [ 29, 32 ] ], "normalized": [] }, { "id": "split_0_train_8590_entity", "type": "progene_text", "text": [ "p55" ], "offsets": [ [ 37, 40 ] ], "normalized": [] }, { "id": "split_0_train_8591_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 70, 75 ] ], "normalized": [] }, { "id": "split_0_train_8592_entity", "type": "progene_text", "text": [ "cofilin" ], "offsets": [ [ 78, 85 ] ], "normalized": [] }, { "id": "split_0_train_8593_entity", "type": "progene_text", "text": [ "p55" ], "offsets": [ [ 140, 143 ] ], "normalized": [] }, { "id": "split_0_train_8594_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 147, 151 ] ], "normalized": [] }, { "id": "split_0_train_8595_entity", "type": "progene_text", "text": [ "ASP56" ], "offsets": [ [ 154, 159 ] ], "normalized": [] }, { "id": "split_0_train_8596_entity", "type": "progene_text", "text": [ "CAP" ], "offsets": [ [ 189, 192 ] ], "normalized": [] }, { "id": "split_0_train_8597_entity", "type": "progene_text", "text": [ "SRV2" ], "offsets": [ [ 195, 199 ] ], "normalized": [] }, { "id": "split_0_train_8598_entity", "type": "progene_text", "text": [ "cyclase - associated protein" ], "offsets": [ [ 202, 230 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5603
split_0_train_5603
[ { "id": "split_0_train_5603_passage", "type": "progene_text", "text": [ "CAP is a bifunctional protein with an N - terminal domain that binds to Ras - responsive adenylyl cyclase and a C - terminal domain that inhibits actin polymerization ." ], "offsets": [ [ 0, 168 ] ] } ]
[ { "id": "split_0_train_8599_entity", "type": "progene_text", "text": [ "CAP" ], "offsets": [ [ 0, 3 ] ], "normalized": [] }, { "id": "split_0_train_8600_entity", "type": "progene_text", "text": [ "Ras" ], "offsets": [ [ 72, 75 ] ], "normalized": [] }, { "id": "split_0_train_8601_entity", "type": "progene_text", "text": [ "adenylyl cyclase" ], "offsets": [ [ 89, 105 ] ], "normalized": [] }, { "id": "split_0_train_8602_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 146, 151 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5604
split_0_train_5604
[ { "id": "split_0_train_5604_passage", "type": "progene_text", "text": [ "Surprisingly , we found that the N - terminal domain of CAP1 , but not the C - terminal domain , is responsible for the interaction with the actin - cofilin complex ." ], "offsets": [ [ 0, 166 ] ] } ]
[ { "id": "split_0_train_8603_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 56, 60 ] ], "normalized": [] }, { "id": "split_0_train_8604_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 141, 146 ] ], "normalized": [] }, { "id": "split_0_train_8605_entity", "type": "progene_text", "text": [ "cofilin" ], "offsets": [ [ 149, 156 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5605
split_0_train_5605
[ { "id": "split_0_train_5605_passage", "type": "progene_text", "text": [ "The N - terminal domain of CAP1 was also found to accelerate the depolymerization of F-actin at the pointed end , which was further enhanced in the presence of cofilin and/or the C - terminal domain of CAP1 ." ], "offsets": [ [ 0, 208 ] ] } ]
[ { "id": "split_0_train_8606_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 27, 31 ] ], "normalized": [] }, { "id": "split_0_train_8607_entity", "type": "progene_text", "text": [ "F-actin" ], "offsets": [ [ 85, 92 ] ], "normalized": [] }, { "id": "split_0_train_8608_entity", "type": "progene_text", "text": [ "cofilin" ], "offsets": [ [ 160, 167 ] ], "normalized": [] }, { "id": "split_0_train_8609_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 202, 206 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5606
split_0_train_5606
[ { "id": "split_0_train_5606_passage", "type": "progene_text", "text": [ "Moreover , CAP1 and its C - terminal domain were observed to facilitate filament elongation at the barbed end and to stimulate ADP-ATP exchange on G-actin , a process that regenerates easily polymerizable G-actin ." ], "offsets": [ [ 0, 214 ] ] } ]
[ { "id": "split_0_train_8610_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 11, 15 ] ], "normalized": [] }, { "id": "split_0_train_8611_entity", "type": "progene_text", "text": [ "G-actin" ], "offsets": [ [ 147, 154 ] ], "normalized": [] }, { "id": "split_0_train_8612_entity", "type": "progene_text", "text": [ "G-actin" ], "offsets": [ [ 205, 212 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5607
split_0_train_5607
[ { "id": "split_0_train_5607_passage", "type": "progene_text", "text": [ "Although cofilin inhibited the nucleotide exchange on G-actin even in the presence of the C - terminal domain of CAP1 , its N - terminal domain relieved this inhibition ." ], "offsets": [ [ 0, 170 ] ] } ]
[ { "id": "split_0_train_8613_entity", "type": "progene_text", "text": [ "cofilin" ], "offsets": [ [ 9, 16 ] ], "normalized": [] }, { "id": "split_0_train_8614_entity", "type": "progene_text", "text": [ "G-actin" ], "offsets": [ [ 54, 61 ] ], "normalized": [] }, { "id": "split_0_train_8615_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 113, 117 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5608
split_0_train_5608
[ { "id": "split_0_train_5608_passage", "type": "progene_text", "text": [ "Thus , CAP1 plays a key role in speeding up the turnover of actin filaments by effectively recycling cofilin and actin and through its effect on both ends of actin filament ." ], "offsets": [ [ 0, 174 ] ] } ]
[ { "id": "split_0_train_8616_entity", "type": "progene_text", "text": [ "CAP1" ], "offsets": [ [ 7, 11 ] ], "normalized": [] }, { "id": "split_0_train_8617_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 60, 65 ] ], "normalized": [] }, { "id": "split_0_train_8618_entity", "type": "progene_text", "text": [ "cofilin" ], "offsets": [ [ 101, 108 ] ], "normalized": [] }, { "id": "split_0_train_8619_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 113, 118 ] ], "normalized": [] }, { "id": "split_0_train_8620_entity", "type": "progene_text", "text": [ "actin" ], "offsets": [ [ 158, 163 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5609
split_0_train_5609
[ { "id": "split_0_train_5609_passage", "type": "progene_text", "text": [ "Expression , modulation and signalling of IL-17 receptor in fibroblast - like synoviocytes of patients with rheumatoid arthritis ." ], "offsets": [ [ 0, 130 ] ] } ]
[ { "id": "split_0_train_8621_entity", "type": "progene_text", "text": [ "IL-17 receptor" ], "offsets": [ [ 42, 56 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5610
split_0_train_5610
[ { "id": "split_0_train_5610_passage", "type": "progene_text", "text": [ "Interleukin-17 ( IL-17 ) has been characterized as a proinflammatory cytokine produced by CD4 + CD45RO + memory T cells ." ], "offsets": [ [ 0, 121 ] ] } ]
[ { "id": "split_0_train_8622_entity", "type": "progene_text", "text": [ "Interleukin-17" ], "offsets": [ [ 0, 14 ] ], "normalized": [] }, { "id": "split_0_train_8623_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 17, 22 ] ], "normalized": [] }, { "id": "split_0_train_8624_entity", "type": "progene_text", "text": [ "cytokine" ], "offsets": [ [ 69, 77 ] ], "normalized": [] }, { "id": "split_0_train_8625_entity", "type": "progene_text", "text": [ "CD4" ], "offsets": [ [ 90, 93 ] ], "normalized": [] }, { "id": "split_0_train_8626_entity", "type": "progene_text", "text": [ "CD45RO" ], "offsets": [ [ 96, 102 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5611
split_0_train_5611
[ { "id": "split_0_train_5611_passage", "type": "progene_text", "text": [ "Overproduction of IL-17 was detected in the synovium of patients with rheumatoid arthritis ( RA ) compared to patients with osteoarthritis ." ], "offsets": [ [ 0, 140 ] ] } ]
[ { "id": "split_0_train_8627_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 18, 23 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5612
split_0_train_5612
[ { "id": "split_0_train_5612_passage", "type": "progene_text", "text": [ "In contrast to the restricted expression of IL-17 , the IL-17 receptor ( IL-17R / CDw217 ) is expressed ubiquitously ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_8628_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 44, 49 ] ], "normalized": [] }, { "id": "split_0_train_8629_entity", "type": "progene_text", "text": [ "IL-17 receptor" ], "offsets": [ [ 56, 70 ] ], "normalized": [] }, { "id": "split_0_train_8630_entity", "type": "progene_text", "text": [ "IL-17R" ], "offsets": [ [ 73, 79 ] ], "normalized": [] }, { "id": "split_0_train_8631_entity", "type": "progene_text", "text": [ "CDw217" ], "offsets": [ [ 82, 88 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5613
split_0_train_5613
[ { "id": "split_0_train_5613_passage", "type": "progene_text", "text": [ "Using a real - time RT - PCR assay , we detected similar absolute levels of IL-17R mRNA expression in fibroblast - like synoviocytes ( SFC ) from patients with RA ( mean 9 pg / microg total RNA ; ranged from 0.1 pg to 96 pg IL-17R mRNA / microg total RNA ) compared to synoviocytes of non - RA patients ." ], "offsets": [ [ 0, 304 ] ] } ]
[ { "id": "split_0_train_8632_entity", "type": "progene_text", "text": [ "IL-17R" ], "offsets": [ [ 76, 82 ] ], "normalized": [] }, { "id": "split_0_train_8633_entity", "type": "progene_text", "text": [ "IL-17R" ], "offsets": [ [ 224, 230 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5614
split_0_train_5614
[ { "id": "split_0_train_5614_passage", "type": "progene_text", "text": [ "Analysis of the IL-17R surface expression confirmed the results obtained for IL-17R mRNA expression ." ], "offsets": [ [ 0, 101 ] ] } ]
[ { "id": "split_0_train_8634_entity", "type": "progene_text", "text": [ "IL-17R" ], "offsets": [ [ 16, 22 ] ], "normalized": [] }, { "id": "split_0_train_8635_entity", "type": "progene_text", "text": [ "IL-17R" ], "offsets": [ [ 77, 83 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5615
split_0_train_5615
[ { "id": "split_0_train_5615_passage", "type": "progene_text", "text": [ "Exposure of SFC to IL-17 led to a mRNA induction of CXC chemokines IL-8 , GRO-alpha and GRO-beta ." ], "offsets": [ [ 0, 98 ] ] } ]
[ { "id": "split_0_train_8636_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 19, 24 ] ], "normalized": [] }, { "id": "split_0_train_8637_entity", "type": "progene_text", "text": [ "CXC chemokines" ], "offsets": [ [ 52, 66 ] ], "normalized": [] }, { "id": "split_0_train_8638_entity", "type": "progene_text", "text": [ "IL-8" ], "offsets": [ [ 67, 71 ] ], "normalized": [] }, { "id": "split_0_train_8639_entity", "type": "progene_text", "text": [ "GRO-alpha" ], "offsets": [ [ 74, 83 ] ], "normalized": [] }, { "id": "split_0_train_8640_entity", "type": "progene_text", "text": [ "GRO-beta" ], "offsets": [ [ 88, 96 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5616
split_0_train_5616
[ { "id": "split_0_train_5616_passage", "type": "progene_text", "text": [ "An anti - IL-17 antibody blocked these effects of IL-17 ." ], "offsets": [ [ 0, 57 ] ] } ]
[ { "id": "split_0_train_8641_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 10, 15 ] ], "normalized": [] }, { "id": "split_0_train_8642_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 50, 55 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5617
split_0_train_5617
[ { "id": "split_0_train_5617_passage", "type": "progene_text", "text": [ "The MAPK p38 appears necessary for the regulation of IL-8 , GRO-alpha and GRO-beta expression as shown by inhibition with SB203580 ." ], "offsets": [ [ 0, 132 ] ] } ]
[ { "id": "split_0_train_8643_entity", "type": "progene_text", "text": [ "MAPK p38" ], "offsets": [ [ 4, 12 ] ], "normalized": [] }, { "id": "split_0_train_8644_entity", "type": "progene_text", "text": [ "IL-8" ], "offsets": [ [ 53, 57 ] ], "normalized": [] }, { "id": "split_0_train_8645_entity", "type": "progene_text", "text": [ "GRO-alpha" ], "offsets": [ [ 60, 69 ] ], "normalized": [] }, { "id": "split_0_train_8646_entity", "type": "progene_text", "text": [ "GRO-beta" ], "offsets": [ [ 74, 82 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5618
split_0_train_5618
[ { "id": "split_0_train_5618_passage", "type": "progene_text", "text": [ "The inhibitors genistein ( tyrosine kinase inhibitor ) and calphostin C ( inhibitor of protein kinase C ) reduced significantly the IL-17 - stimulated mRNA expression of IL-8 , GRO-alpha and GRO-beta in SFC , whereas PD98059 ( inhibitor of MEK-1/2 ) was without effect ." ], "offsets": [ [ 0, 270 ] ] } ]
[ { "id": "split_0_train_8647_entity", "type": "progene_text", "text": [ "tyrosine kinase" ], "offsets": [ [ 27, 42 ] ], "normalized": [] }, { "id": "split_0_train_8648_entity", "type": "progene_text", "text": [ "protein kinase C" ], "offsets": [ [ 87, 103 ] ], "normalized": [] }, { "id": "split_0_train_8649_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 132, 137 ] ], "normalized": [] }, { "id": "split_0_train_8650_entity", "type": "progene_text", "text": [ "IL-8" ], "offsets": [ [ 170, 174 ] ], "normalized": [] }, { "id": "split_0_train_8651_entity", "type": "progene_text", "text": [ "GRO-alpha" ], "offsets": [ [ 177, 186 ] ], "normalized": [] }, { "id": "split_0_train_8652_entity", "type": "progene_text", "text": [ "GRO-beta" ], "offsets": [ [ 191, 199 ] ], "normalized": [] }, { "id": "split_0_train_8653_entity", "type": "progene_text", "text": [ "MEK-1/2" ], "offsets": [ [ 240, 247 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5619
split_0_train_5619
[ { "id": "split_0_train_5619_passage", "type": "progene_text", "text": [ "Pharmacological drugs used in therapy of RA , such as cyclosporin and methotrexate , induced a fourfold increase of IL-17R mRNA expression and augmented the IL-17 - stimulated IL-8 expression ." ], "offsets": [ [ 0, 193 ] ] } ]
[ { "id": "split_0_train_8654_entity", "type": "progene_text", "text": [ "IL-17R" ], "offsets": [ [ 116, 122 ] ], "normalized": [] }, { "id": "split_0_train_8655_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 157, 162 ] ], "normalized": [] }, { "id": "split_0_train_8656_entity", "type": "progene_text", "text": [ "IL-8" ], "offsets": [ [ 176, 180 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5620
split_0_train_5620
[ { "id": "split_0_train_5620_passage", "type": "progene_text", "text": [ "Our results support the hypothesis that IL-17 / IL-17R may play a significant role in the pathogenesis of RA contributing to an unbalanced production of cytokines as well as participating in connective tissue remodelling ." ], "offsets": [ [ 0, 222 ] ] } ]
[ { "id": "split_0_train_8657_entity", "type": "progene_text", "text": [ "IL-17" ], "offsets": [ [ 40, 45 ] ], "normalized": [] }, { "id": "split_0_train_8658_entity", "type": "progene_text", "text": [ "IL-17R" ], "offsets": [ [ 48, 54 ] ], "normalized": [] }, { "id": "split_0_train_8659_entity", "type": "progene_text", "text": [ "cytokines" ], "offsets": [ [ 153, 162 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5621
split_0_train_5621
[ { "id": "split_0_train_5621_passage", "type": "progene_text", "text": [ "Proteinase 3 and dihydrolipoamide dehydrogenase ( E3 ) are major autoantigens in hepatitis C virus ( HCV ) infection ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_8660_entity", "type": "progene_text", "text": [ "Proteinase 3" ], "offsets": [ [ 0, 12 ] ], "normalized": [] }, { "id": "split_0_train_8661_entity", "type": "progene_text", "text": [ "dihydrolipoamide dehydrogenase" ], "offsets": [ [ 17, 47 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5622
split_0_train_5622
[ { "id": "split_0_train_5622_passage", "type": "progene_text", "text": [ "Hepatitis C virus ( HCV ) infection has been found to be strikingly associated with autoimmune phenomena ." ], "offsets": [ [ 0, 106 ] ] } ]
[]
[]
[]
[]
split_0_train_5623
split_0_train_5623
[ { "id": "split_0_train_5623_passage", "type": "progene_text", "text": [ "The aim of the present study was to investigate the presence of various autoantibodies in patients with HCV infection ." ], "offsets": [ [ 0, 119 ] ] } ]
[]
[]
[]
[]
split_0_train_5624
split_0_train_5624
[ { "id": "split_0_train_5624_passage", "type": "progene_text", "text": [ "Anti - neutrophil cytoplamic antibody ( ANCA ) , anti - dihydrolipoamide dehydrogenase ( anti - E3 ) , rheumatoid factor ( RF ) , anti - dihydrolipoamide acetyltransferase ( anti - E2 ) , anti - SS-A / Ro ( 60 kD ) , anti - SS-A / Ro ( 52 kD ) , anti - SS-B / La , anti - topoisomerase II ( anti - topo II ) , anti - cardiolipin ( aCL ) , anti - dsDNA , anti - ssDNA , anti - nuclear antibodies ( ANA ) , anti - proteinase 3 ( anti - Pr3 ) and anti - myeloperoxidase ( anti - MPO ) were determined in sera from 516 patients with HCV infection , 11 with primary biliary cirrhosis ( PBC ) and 44 healthy controls ." ], "offsets": [ [ 0, 612 ] ] } ]
[ { "id": "split_0_train_8662_entity", "type": "progene_text", "text": [ "dihydrolipoamide dehydrogenase" ], "offsets": [ [ 56, 86 ] ], "normalized": [] }, { "id": "split_0_train_8663_entity", "type": "progene_text", "text": [ "rheumatoid factor" ], "offsets": [ [ 103, 120 ] ], "normalized": [] }, { "id": "split_0_train_8664_entity", "type": "progene_text", "text": [ "RF" ], "offsets": [ [ 123, 125 ] ], "normalized": [] }, { "id": "split_0_train_8665_entity", "type": "progene_text", "text": [ "dihydrolipoamide acetyltransferase" ], "offsets": [ [ 137, 171 ] ], "normalized": [] }, { "id": "split_0_train_8666_entity", "type": "progene_text", "text": [ "SS-A" ], "offsets": [ [ 195, 199 ] ], "normalized": [] }, { "id": "split_0_train_8667_entity", "type": "progene_text", "text": [ "Ro ( 60 kD )" ], "offsets": [ [ 202, 214 ] ], "normalized": [] }, { "id": "split_0_train_8668_entity", "type": "progene_text", "text": [ "SS-A" ], "offsets": [ [ 224, 228 ] ], "normalized": [] }, { "id": "split_0_train_8669_entity", "type": "progene_text", "text": [ "Ro ( 52 kD )" ], "offsets": [ [ 231, 243 ] ], "normalized": [] }, { "id": "split_0_train_8670_entity", "type": "progene_text", "text": [ "SS-B" ], "offsets": [ [ 253, 257 ] ], "normalized": [] }, { "id": "split_0_train_8671_entity", "type": "progene_text", "text": [ "La" ], "offsets": [ [ 260, 262 ] ], "normalized": [] }, { "id": "split_0_train_8672_entity", "type": "progene_text", "text": [ "topoisomerase II" ], "offsets": [ [ 272, 288 ] ], "normalized": [] }, { "id": "split_0_train_8673_entity", "type": "progene_text", "text": [ "topo II" ], "offsets": [ [ 298, 305 ] ], "normalized": [] }, { "id": "split_0_train_8674_entity", "type": "progene_text", "text": [ "proteinase 3" ], "offsets": [ [ 412, 424 ] ], "normalized": [] }, { "id": "split_0_train_8675_entity", "type": "progene_text", "text": [ "Pr3" ], "offsets": [ [ 434, 437 ] ], "normalized": [] }, { "id": "split_0_train_8676_entity", "type": "progene_text", "text": [ "myeloperoxidase" ], "offsets": [ [ 451, 466 ] ], "normalized": [] }, { "id": "split_0_train_8677_entity", "type": "progene_text", "text": [ "MPO" ], "offsets": [ [ 476, 479 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5625
split_0_train_5625
[ { "id": "split_0_train_5625_passage", "type": "progene_text", "text": [ "Assays employed were indirect immunofluoresence , the particle latex agglutination test , enzyme - linked immunosorbent assay ( ELISA ) and immunoblotting ." ], "offsets": [ [ 0, 156 ] ] } ]
[]
[]
[]
[]
split_0_train_5626
split_0_train_5626
[ { "id": "split_0_train_5626_passage", "type": "progene_text", "text": [ "ANCA , anti - E3 antibody and RF were positive in 278 / 516 ( 55.6 % ) , 276 / 516 ( 53.3 % ) and 288 / 516 ( 56 % ) patients with HCV infection , respectively ." ], "offsets": [ [ 0, 161 ] ] } ]
[ { "id": "split_0_train_8678_entity", "type": "progene_text", "text": [ "RF" ], "offsets": [ [ 30, 32 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5627
split_0_train_5627
[ { "id": "split_0_train_5627_passage", "type": "progene_text", "text": [ "Positivity for ANA was present in 15.8 % , anti - ssDNA in 15.6 % , anti - dsDNA in 8.5 % , aCL in 5 % , anti - SS - B / La in 4.1 % , anti - SS-A / Ro ( 60 kD ) in 3.9 % , anti - E2 in 3.3 % and anti - SSA / Ro ( 52 kD ) in 1.2 % , anti - MPO in 4.8 % , anti - Topo II and anti - actinin in 0 % ." ], "offsets": [ [ 0, 297 ] ] } ]
[ { "id": "split_0_train_8679_entity", "type": "progene_text", "text": [ "SS - B" ], "offsets": [ [ 112, 118 ] ], "normalized": [] }, { "id": "split_0_train_8680_entity", "type": "progene_text", "text": [ "La" ], "offsets": [ [ 121, 123 ] ], "normalized": [] }, { "id": "split_0_train_8681_entity", "type": "progene_text", "text": [ "SS-A" ], "offsets": [ [ 142, 146 ] ], "normalized": [] }, { "id": "split_0_train_8682_entity", "type": "progene_text", "text": [ "Ro ( 60 kD )" ], "offsets": [ [ 149, 161 ] ], "normalized": [] }, { "id": "split_0_train_8683_entity", "type": "progene_text", "text": [ "SSA" ], "offsets": [ [ 203, 206 ] ], "normalized": [] }, { "id": "split_0_train_8684_entity", "type": "progene_text", "text": [ "Ro ( 52 kD )" ], "offsets": [ [ 209, 221 ] ], "normalized": [] }, { "id": "split_0_train_8685_entity", "type": "progene_text", "text": [ "MPO" ], "offsets": [ [ 240, 243 ] ], "normalized": [] }, { "id": "split_0_train_8686_entity", "type": "progene_text", "text": [ "Topo II" ], "offsets": [ [ 262, 269 ] ], "normalized": [] }, { "id": "split_0_train_8687_entity", "type": "progene_text", "text": [ "actinin" ], "offsets": [ [ 281, 288 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5628
split_0_train_5628
[ { "id": "split_0_train_5628_passage", "type": "progene_text", "text": [ "All sera with ANCA showed c-ANCA patterns and contained anti - PR3 specificity ." ], "offsets": [ [ 0, 80 ] ] } ]
[ { "id": "split_0_train_8688_entity", "type": "progene_text", "text": [ "PR3" ], "offsets": [ [ 63, 66 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5629
split_0_train_5629
[ { "id": "split_0_train_5629_passage", "type": "progene_text", "text": [ "HCV patients with ANCA showed a higher prevalence of skin involvement , anaemia , abnormal liver function and alpha-Fetoprotein ( alpha-FP ) ." ], "offsets": [ [ 0, 142 ] ] } ]
[ { "id": "split_0_train_8689_entity", "type": "progene_text", "text": [ "alpha-Fetoprotein" ], "offsets": [ [ 110, 127 ] ], "normalized": [] }, { "id": "split_0_train_8690_entity", "type": "progene_text", "text": [ "alpha-FP" ], "offsets": [ [ 130, 138 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5630
split_0_train_5630
[ { "id": "split_0_train_5630_passage", "type": "progene_text", "text": [ "HCV patients with anti - E3 antibodies showed a higher prevalence of liver cirrhosis , arthritis , abnormal liver function and elevated alpha-FP levels ." ], "offsets": [ [ 0, 153 ] ] } ]
[ { "id": "split_0_train_8691_entity", "type": "progene_text", "text": [ "alpha-FP" ], "offsets": [ [ 136, 144 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5631
split_0_train_5631
[ { "id": "split_0_train_5631_passage", "type": "progene_text", "text": [ "The prevalence of autoantibodies was not affected by treatment with interferon-alpha ( IFN-alpha ) ." ], "offsets": [ [ 0, 100 ] ] } ]
[ { "id": "split_0_train_8692_entity", "type": "progene_text", "text": [ "interferon-alpha" ], "offsets": [ [ 68, 84 ] ], "normalized": [] }, { "id": "split_0_train_8693_entity", "type": "progene_text", "text": [ "IFN-alpha" ], "offsets": [ [ 87, 96 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5632
split_0_train_5632
[ { "id": "split_0_train_5632_passage", "type": "progene_text", "text": [ "In conclusion , autoantibodies are commonly found in patients with HCV infection ." ], "offsets": [ [ 0, 82 ] ] } ]
[]
[]
[]
[]
split_0_train_5633
split_0_train_5633
[ { "id": "split_0_train_5633_passage", "type": "progene_text", "text": [ "There is a high prevalence of anti - E3 , ANCA and RF in these patients ." ], "offsets": [ [ 0, 73 ] ] } ]
[ { "id": "split_0_train_8694_entity", "type": "progene_text", "text": [ "RF" ], "offsets": [ [ 51, 53 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5634
split_0_train_5634
[ { "id": "split_0_train_5634_passage", "type": "progene_text", "text": [ "Proteinase 3 and E3 are the major target antigens in HCV infection ." ], "offsets": [ [ 0, 68 ] ] } ]
[ { "id": "split_0_train_8695_entity", "type": "progene_text", "text": [ "Proteinase 3" ], "offsets": [ [ 0, 12 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5635
split_0_train_5635
[ { "id": "split_0_train_5635_passage", "type": "progene_text", "text": [ "HCV may be regarded as a possible causative factor in ANCA - related vasculitis ." ], "offsets": [ [ 0, 81 ] ] } ]
[]
[]
[]
[]
split_0_train_5636
split_0_train_5636
[ { "id": "split_0_train_5636_passage", "type": "progene_text", "text": [ "The Tol / Pal system function requires an interaction between the C - terminal domain of TolA and the N - terminal domain of TolB ." ], "offsets": [ [ 0, 131 ] ] } ]
[ { "id": "split_0_train_8696_entity", "type": "progene_text", "text": [ "Tol" ], "offsets": [ [ 4, 7 ] ], "normalized": [] }, { "id": "split_0_train_8697_entity", "type": "progene_text", "text": [ "Pal" ], "offsets": [ [ 10, 13 ] ], "normalized": [] }, { "id": "split_0_train_8698_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 89, 93 ] ], "normalized": [] }, { "id": "split_0_train_8699_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 125, 129 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5637
split_0_train_5637
[ { "id": "split_0_train_5637_passage", "type": "progene_text", "text": [ "The Tol / Pal system of Escherichia coli is composed of the YbgC , TolQ , TolA , TolR , TolB , Pal and YbgF proteins ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_8700_entity", "type": "progene_text", "text": [ "Tol" ], "offsets": [ [ 4, 7 ] ], "normalized": [] }, { "id": "split_0_train_8701_entity", "type": "progene_text", "text": [ "Pal" ], "offsets": [ [ 10, 13 ] ], "normalized": [] }, { "id": "split_0_train_8702_entity", "type": "progene_text", "text": [ "YbgC" ], "offsets": [ [ 60, 64 ] ], "normalized": [] }, { "id": "split_0_train_8703_entity", "type": "progene_text", "text": [ "TolQ" ], "offsets": [ [ 67, 71 ] ], "normalized": [] }, { "id": "split_0_train_8704_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 74, 78 ] ], "normalized": [] }, { "id": "split_0_train_8705_entity", "type": "progene_text", "text": [ "TolR" ], "offsets": [ [ 81, 85 ] ], "normalized": [] }, { "id": "split_0_train_8706_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 88, 92 ] ], "normalized": [] }, { "id": "split_0_train_8707_entity", "type": "progene_text", "text": [ "Pal" ], "offsets": [ [ 95, 98 ] ], "normalized": [] }, { "id": "split_0_train_8708_entity", "type": "progene_text", "text": [ "YbgF" ], "offsets": [ [ 103, 107 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5638
split_0_train_5638
[ { "id": "split_0_train_5638_passage", "type": "progene_text", "text": [ "It is involved in maintaining the integrity of the outer membrane , and is required for the uptake of group A colicins and DNA of filamentous bacteriophages ." ], "offsets": [ [ 0, 158 ] ] } ]
[]
[]
[]
[]
split_0_train_5639
split_0_train_5639
[ { "id": "split_0_train_5639_passage", "type": "progene_text", "text": [ "To identify new interactions between the components of the Tol / Pal system and gain insight into the mechanism of colicin import , we performed a yeast two - hybrid screen using the different components of the Tol / Pal system and colicin A ." ], "offsets": [ [ 0, 243 ] ] } ]
[ { "id": "split_0_train_8709_entity", "type": "progene_text", "text": [ "Tol" ], "offsets": [ [ 59, 62 ] ], "normalized": [] }, { "id": "split_0_train_8710_entity", "type": "progene_text", "text": [ "Pal" ], "offsets": [ [ 65, 68 ] ], "normalized": [] }, { "id": "split_0_train_8711_entity", "type": "progene_text", "text": [ "Tol" ], "offsets": [ [ 211, 214 ] ], "normalized": [] }, { "id": "split_0_train_8712_entity", "type": "progene_text", "text": [ "Pal" ], "offsets": [ [ 217, 220 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5640
split_0_train_5640
[ { "id": "split_0_train_5640_passage", "type": "progene_text", "text": [ "Using this system , we confirmed the already known interactions and identified several new interactions ." ], "offsets": [ [ 0, 105 ] ] } ]
[]
[]
[]
[]
split_0_train_5641
split_0_train_5641
[ { "id": "split_0_train_5641_passage", "type": "progene_text", "text": [ "TolB dimerizes and the periplasmic domain of TolA interacts with YbgF and TolB ." ], "offsets": [ [ 0, 80 ] ] } ]
[ { "id": "split_0_train_8713_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_8714_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 45, 49 ] ], "normalized": [] }, { "id": "split_0_train_8715_entity", "type": "progene_text", "text": [ "YbgF" ], "offsets": [ [ 65, 69 ] ], "normalized": [] }, { "id": "split_0_train_8716_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 74, 78 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5642
split_0_train_5642
[ { "id": "split_0_train_5642_passage", "type": "progene_text", "text": [ "Our results indicate that the central domain of TolA ( TolAII ) is sufficient to interact with YbgF , that the C - terminal domain of TolA ( TolAIII ) is sufficient to interact with TolB , and that the amino terminal domain of TolB ( D1 ) is sufficient to bind TolAIII ." ], "offsets": [ [ 0, 270 ] ] } ]
[ { "id": "split_0_train_8717_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 48, 52 ] ], "normalized": [] }, { "id": "split_0_train_8718_entity", "type": "progene_text", "text": [ "YbgF" ], "offsets": [ [ 95, 99 ] ], "normalized": [] }, { "id": "split_0_train_8719_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 134, 138 ] ], "normalized": [] }, { "id": "split_0_train_8720_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 182, 186 ] ], "normalized": [] }, { "id": "split_0_train_8721_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 227, 231 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5643
split_0_train_5643
[ { "id": "split_0_train_5643_passage", "type": "progene_text", "text": [ "The TolA / TolB interaction was confirmed by cross - linking experiments on purified proteins ." ], "offsets": [ [ 0, 95 ] ] } ]
[ { "id": "split_0_train_8722_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 4, 8 ] ], "normalized": [] }, { "id": "split_0_train_8723_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 11, 15 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5644
split_0_train_5644
[ { "id": "split_0_train_5644_passage", "type": "progene_text", "text": [ "Moreover , we show that the interaction between TolA and TolB is required for the uptake of colicin A and for the membrane integrity ." ], "offsets": [ [ 0, 134 ] ] } ]
[ { "id": "split_0_train_8724_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 48, 52 ] ], "normalized": [] }, { "id": "split_0_train_8725_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 57, 61 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5645
split_0_train_5645
[ { "id": "split_0_train_5645_passage", "type": "progene_text", "text": [ "These results demonstrate that the TolA / TolB interaction allows the formation of a trans - envelope complex that brings the inner and outer membranes in close proximity ." ], "offsets": [ [ 0, 172 ] ] } ]
[ { "id": "split_0_train_8726_entity", "type": "progene_text", "text": [ "TolA" ], "offsets": [ [ 35, 39 ] ], "normalized": [] }, { "id": "split_0_train_8727_entity", "type": "progene_text", "text": [ "TolB" ], "offsets": [ [ 42, 46 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5646
split_0_train_5646
[ { "id": "split_0_train_5646_passage", "type": "progene_text", "text": [ "Inactivating mutations of CASP10 gene in non - Hodgkin lymphomas ." ], "offsets": [ [ 0, 66 ] ] } ]
[ { "id": "split_0_train_8728_entity", "type": "progene_text", "text": [ "CASP10" ], "offsets": [ [ 26, 32 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5647
split_0_train_5647
[ { "id": "split_0_train_5647_passage", "type": "progene_text", "text": [ "Caspase 10 ( Mch4 / FLICE2 ) is a caspase homologous to caspase 8 ." ], "offsets": [ [ 0, 67 ] ] } ]
[ { "id": "split_0_train_8729_entity", "type": "progene_text", "text": [ "Caspase 10" ], "offsets": [ [ 0, 10 ] ], "normalized": [] }, { "id": "split_0_train_8730_entity", "type": "progene_text", "text": [ "Mch4" ], "offsets": [ [ 13, 17 ] ], "normalized": [] }, { "id": "split_0_train_8731_entity", "type": "progene_text", "text": [ "FLICE2" ], "offsets": [ [ 20, 26 ] ], "normalized": [] }, { "id": "split_0_train_8732_entity", "type": "progene_text", "text": [ "caspase 8" ], "offsets": [ [ 56, 65 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5648
split_0_train_5648
[ { "id": "split_0_train_5648_passage", "type": "progene_text", "text": [ "A recent report described that inherited CASP10 gene mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome ( ALPS ) ." ], "offsets": [ [ 0, 175 ] ] } ]
[ { "id": "split_0_train_8733_entity", "type": "progene_text", "text": [ "CASP10" ], "offsets": [ [ 41, 47 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5649
split_0_train_5649
[ { "id": "split_0_train_5649_passage", "type": "progene_text", "text": [ "In this study , to explore the possibility that mutation of this gene might be involved in the development of non - Hodgkin lymphoma ( NHL ) , we have analyzed the entire coding region and all splice sites of the CASP10 gene for the detection of somatic mutations in 117 human NHLs ." ], "offsets": [ [ 0, 283 ] ] } ]
[ { "id": "split_0_train_8734_entity", "type": "progene_text", "text": [ "CASP10" ], "offsets": [ [ 213, 219 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5650
split_0_train_5650
[ { "id": "split_0_train_5650_passage", "type": "progene_text", "text": [ "Overall , 17 NHLs ( 14.5 % ) were found to have CASP10 mutations , which were identified in the coding regions of the prodomain ( n = 3 ) , the p17 large protease subunit ( n = 11 ) , and the p12 small protease subunit ( n = 3 ) ." ], "offsets": [ [ 0, 230 ] ] } ]
[ { "id": "split_0_train_8735_entity", "type": "progene_text", "text": [ "CASP10" ], "offsets": [ [ 48, 54 ] ], "normalized": [] }, { "id": "split_0_train_8736_entity", "type": "progene_text", "text": [ "protease" ], "offsets": [ [ 154, 162 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5651
split_0_train_5651
[ { "id": "split_0_train_5651_passage", "type": "progene_text", "text": [ "We expressed the tumor - derived caspase 10 mutants in 293 cells and found that apoptosis was suppressed ." ], "offsets": [ [ 0, 106 ] ] } ]
[ { "id": "split_0_train_8737_entity", "type": "progene_text", "text": [ "caspase 10" ], "offsets": [ [ 33, 43 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5652
split_0_train_5652
[ { "id": "split_0_train_5652_passage", "type": "progene_text", "text": [ "These data suggest that the inactivating mutations of the CASP10 gene might lead to the loss of its apoptotic function and contribute to the pathogenesis of some human NHLs ." ], "offsets": [ [ 0, 174 ] ] } ]
[ { "id": "split_0_train_8738_entity", "type": "progene_text", "text": [ "CASP10" ], "offsets": [ [ 58, 64 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5653
split_0_train_5653
[ { "id": "split_0_train_5653_passage", "type": "progene_text", "text": [ "Photoreceptor renewal : a role for peripherin / rds ." ], "offsets": [ [ 0, 53 ] ] } ]
[ { "id": "split_0_train_8739_entity", "type": "progene_text", "text": [ "Photoreceptor" ], "offsets": [ [ 0, 13 ] ], "normalized": [] }, { "id": "split_0_train_8740_entity", "type": "progene_text", "text": [ "peripherin" ], "offsets": [ [ 35, 45 ] ], "normalized": [] }, { "id": "split_0_train_8741_entity", "type": "progene_text", "text": [ "rds" ], "offsets": [ [ 48, 51 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5654
split_0_train_5654
[ { "id": "split_0_train_5654_passage", "type": "progene_text", "text": [ "Visual transduction begins with the detection of light within the photoreceptor cell layer of the retina ." ], "offsets": [ [ 0, 106 ] ] } ]
[]
[]
[]
[]
split_0_train_5655
split_0_train_5655
[ { "id": "split_0_train_5655_passage", "type": "progene_text", "text": [ "Within this layer , specialized cells , termed rods and cones , contain the proteins responsible for light capture and its transduction to nerve impulses ." ], "offsets": [ [ 0, 155 ] ] } ]
[]
[]
[]
[]
split_0_train_5656
split_0_train_5656
[ { "id": "split_0_train_5656_passage", "type": "progene_text", "text": [ "The phototransductive proteins reside within an outer segment region that is connected to an inner segment by a thin stalk rich in cytoskeletal elements ." ], "offsets": [ [ 0, 154 ] ] } ]
[]
[]
[]
[]
split_0_train_5657
split_0_train_5657
[ { "id": "split_0_train_5657_passage", "type": "progene_text", "text": [ "A unique property of the outer segments is the presence of an elaborate intracellular membrane system that holds the phototransduction proteins and provides the requisite lipid environment ." ], "offsets": [ [ 0, 190 ] ] } ]
[]
[]
[]
[]
split_0_train_5658
split_0_train_5658
[ { "id": "split_0_train_5658_passage", "type": "progene_text", "text": [ "The maintenance of normal physiological function requires that these postmitotic cells retain the unique structure of the outer segment regions -- stacks of membrane saccules in the case of rods and a continuous infolding of membrane in the case of cones ." ], "offsets": [ [ 0, 256 ] ] } ]
[]
[]
[]
[]
split_0_train_5659
split_0_train_5659
[ { "id": "split_0_train_5659_passage", "type": "progene_text", "text": [ "Both photoreceptor rod and cone cells achieve this through a series of coordinated steps ." ], "offsets": [ [ 0, 90 ] ] } ]
[ { "id": "split_0_train_8742_entity", "type": "progene_text", "text": [ "photoreceptor" ], "offsets": [ [ 5, 18 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5660
split_0_train_5660
[ { "id": "split_0_train_5660_passage", "type": "progene_text", "text": [ "As new membranous material is synthesized , transported , and incorporated into newly forming outer segment membranes , a compensatory shedding of older membranous material occurs , thereby maintaining the segment at a constant length ." ], "offsets": [ [ 0, 236 ] ] } ]
[]
[]
[]
[]
split_0_train_5661
split_0_train_5661
[ { "id": "split_0_train_5661_passage", "type": "progene_text", "text": [ "These processes are collectively referred to as ROS ( rod outer segment ) or COS ( cone outer segment ) renewal ." ], "offsets": [ [ 0, 113 ] ] } ]
[]
[]
[]
[]
split_0_train_5662
split_0_train_5662
[ { "id": "split_0_train_5662_passage", "type": "progene_text", "text": [ "We review the cellular and molecular events responsible for these renewal processes and present the recent but compelling evidence , drawn from molecular genetic , biochemical , and biophysical approaches , pointing to an essential role for a unique tetraspanning membrane protein , called peripherin / rds , in the processes of disk morphogenesis ." ], "offsets": [ [ 0, 349 ] ] } ]
[ { "id": "split_0_train_8743_entity", "type": "progene_text", "text": [ "peripherin" ], "offsets": [ [ 290, 300 ] ], "normalized": [] }, { "id": "split_0_train_8744_entity", "type": "progene_text", "text": [ "rds" ], "offsets": [ [ 303, 306 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5663
split_0_train_5663
[ { "id": "split_0_train_5663_passage", "type": "progene_text", "text": [ "Human uroplakin lb gene structure and promoter analysis ." ], "offsets": [ [ 0, 57 ] ] } ]
[ { "id": "split_0_train_8745_entity", "type": "progene_text", "text": [ "uroplakin lb" ], "offsets": [ [ 6, 18 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5664
split_0_train_5664
[ { "id": "split_0_train_5664_passage", "type": "progene_text", "text": [ "The uroplakin Ib ( UPIb ) gene is predominantly expressed in urothelium and is overexpressed in 50 % of transitional cell carcinoma ( TCC ) ." ], "offsets": [ [ 0, 141 ] ] } ]
[ { "id": "split_0_train_8746_entity", "type": "progene_text", "text": [ "uroplakin Ib" ], "offsets": [ [ 4, 16 ] ], "normalized": [] }, { "id": "split_0_train_8747_entity", "type": "progene_text", "text": [ "UPIb" ], "offsets": [ [ 19, 23 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5665
split_0_train_5665
[ { "id": "split_0_train_5665_passage", "type": "progene_text", "text": [ "Molecular cloning of the genomic 5' region and comparison to a chromosome 3q genomic contig determined that the gene spans 31 kb and has eight exons including a noncoding exon 1 ." ], "offsets": [ [ 0, 179 ] ] } ]
[]
[]
[]
[]
split_0_train_5666
split_0_train_5666
[ { "id": "split_0_train_5666_passage", "type": "progene_text", "text": [ "Multiple transcription start sites were identified in exon 1 by 5'RACE and ribonuclease protection assay ( RPA ) ." ], "offsets": [ [ 0, 114 ] ] } ]
[]
[]
[]
[]
split_0_train_5667
split_0_train_5667
[ { "id": "split_0_train_5667_passage", "type": "progene_text", "text": [ "In vitro reporter gene analysis was performed with 2.3 kb of genomic DNA sequence flanking the 5' end of UPIb ." ], "offsets": [ [ 0, 111 ] ] } ]
[ { "id": "split_0_train_8748_entity", "type": "progene_text", "text": [ "UPIb" ], "offsets": [ [ 105, 109 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5668
split_0_train_5668
[ { "id": "split_0_train_5668_passage", "type": "progene_text", "text": [ "A 235 - bp 5' fragment that included UPIb exon 1 generated strong transcriptional activity in normal and malignant human urothelial cell lines ." ], "offsets": [ [ 0, 144 ] ] } ]
[ { "id": "split_0_train_8749_entity", "type": "progene_text", "text": [ "UPIb" ], "offsets": [ [ 37, 41 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5669
split_0_train_5669
[ { "id": "split_0_train_5669_passage", "type": "progene_text", "text": [ "Established malignant cell lines had greater transcriptional activity from the UPIb promoter than normal human cells ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_8750_entity", "type": "progene_text", "text": [ "UPIb" ], "offsets": [ [ 79, 83 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5670
split_0_train_5670
[ { "id": "split_0_train_5670_passage", "type": "progene_text", "text": [ "The identification of a functional human UPIb gene promoter may find application in targeting gene therapy strategies for bladder cancer ." ], "offsets": [ [ 0, 138 ] ] } ]
[ { "id": "split_0_train_8751_entity", "type": "progene_text", "text": [ "UPIb" ], "offsets": [ [ 41, 45 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5671
split_0_train_5671
[ { "id": "split_0_train_5671_passage", "type": "progene_text", "text": [ "Normalization of natural killer cell function and phenotype with effective anti - HIV therapy and the role of IL-10 ." ], "offsets": [ [ 0, 117 ] ] } ]
[ { "id": "split_0_train_8752_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 110, 115 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5672
split_0_train_5672
[ { "id": "split_0_train_5672_passage", "type": "progene_text", "text": [ "OBJECTIVES :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_5673
split_0_train_5673
[ { "id": "split_0_train_5673_passage", "type": "progene_text", "text": [ "Natural killer ( NK ) cell function is likely to be important in controlling HIV infection and opportunistic pathogens ." ], "offsets": [ [ 0, 120 ] ] } ]
[]
[]
[]
[]
split_0_train_5674
split_0_train_5674
[ { "id": "split_0_train_5674_passage", "type": "progene_text", "text": [ "We therefore evaluated NK function and phenotype over the course of antiretroviral therapy ( ART ) and examined the potential mechanisms of altered NK activity in HIV infection ." ], "offsets": [ [ 0, 178 ] ] } ]
[]
[]
[]
[]
split_0_train_5675
split_0_train_5675
[ { "id": "split_0_train_5675_passage", "type": "progene_text", "text": [ "METHODS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_5676
split_0_train_5676
[ { "id": "split_0_train_5676_passage", "type": "progene_text", "text": [ "We measured NK cell percentage , NK cytolytic activity ( both by flow cytometry ) and plasma IL-10 concentrations ( by enzyme - linked immunosorbent assay ) in 10 HIV - seropositive patients before and over one year of effective ART ." ], "offsets": [ [ 0, 234 ] ] } ]
[ { "id": "split_0_train_8753_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 93, 98 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5677
split_0_train_5677
[ { "id": "split_0_train_5677_passage", "type": "progene_text", "text": [ "To examine potential mechanisms of altered NK activity , we measured NK receptor expression in ART treated and untreated HIV - positive individuals by flow cytometry ." ], "offsets": [ [ 0, 167 ] ] } ]
[]
[]
[]
[]
split_0_train_5678
split_0_train_5678
[ { "id": "split_0_train_5678_passage", "type": "progene_text", "text": [ "As IL-10 enhances NK activity , we studied the effect of IL-10 on NK receptor expression and activity in peripheral blood mononuclear cells ( PBMC ) from HIV - seronegative individuals ." ], "offsets": [ [ 0, 186 ] ] } ]
[ { "id": "split_0_train_8754_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 3, 8 ] ], "normalized": [] }, { "id": "split_0_train_8755_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 57, 62 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5679
split_0_train_5679
[ { "id": "split_0_train_5679_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_5680
split_0_train_5680
[ { "id": "split_0_train_5680_passage", "type": "progene_text", "text": [ "NK cytolytic activity was elevated in HIV infection and decreased with ART to levels observed in HIV - negative individuals ." ], "offsets": [ [ 0, 125 ] ] } ]
[]
[]
[]
[]
split_0_train_5681
split_0_train_5681
[ { "id": "split_0_train_5681_passage", "type": "progene_text", "text": [ "A greater proportion of NK cells from untreated HIV - positive individuals expressed the NK receptors CD158a and CD161 than either HIV - negative volunteers or effectively treated HIV - positive patients ." ], "offsets": [ [ 0, 205 ] ] } ]
[ { "id": "split_0_train_8756_entity", "type": "progene_text", "text": [ "CD158a" ], "offsets": [ [ 102, 108 ] ], "normalized": [] }, { "id": "split_0_train_8757_entity", "type": "progene_text", "text": [ "CD161" ], "offsets": [ [ 113, 118 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5682
split_0_train_5682
[ { "id": "split_0_train_5682_passage", "type": "progene_text", "text": [ "NK cells from PBMC incubated with IL-10 demonstrated increases in CD158a , CD161 and CD94 expression and increases in cytolytic activity ." ], "offsets": [ [ 0, 138 ] ] } ]
[ { "id": "split_0_train_8758_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 34, 39 ] ], "normalized": [] }, { "id": "split_0_train_8759_entity", "type": "progene_text", "text": [ "CD158a" ], "offsets": [ [ 66, 72 ] ], "normalized": [] }, { "id": "split_0_train_8760_entity", "type": "progene_text", "text": [ "CD161" ], "offsets": [ [ 75, 80 ] ], "normalized": [] }, { "id": "split_0_train_8761_entity", "type": "progene_text", "text": [ "CD94" ], "offsets": [ [ 85, 89 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5683
split_0_train_5683
[ { "id": "split_0_train_5683_passage", "type": "progene_text", "text": [ "The treatment - associated decrease in NK activity paralleled a decrease in IL-10 production ." ], "offsets": [ [ 0, 94 ] ] } ]
[ { "id": "split_0_train_8762_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 76, 81 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5684
split_0_train_5684
[ { "id": "split_0_train_5684_passage", "type": "progene_text", "text": [ "CONCLUSION :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_5685
split_0_train_5685
[ { "id": "split_0_train_5685_passage", "type": "progene_text", "text": [ "The observation that IL-10 alters NK receptor expression similar to that observed in HIV infection , and the fact that NK receptor expression and activity normalize in parallel with ART - induced reduction of circulating IL-10 levels supports a role for IL-10 in NK cell activity and HIV immunopathogenesis ." ], "offsets": [ [ 0, 308 ] ] } ]
[ { "id": "split_0_train_8763_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 21, 26 ] ], "normalized": [] }, { "id": "split_0_train_8764_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 221, 226 ] ], "normalized": [] }, { "id": "split_0_train_8765_entity", "type": "progene_text", "text": [ "IL-10" ], "offsets": [ [ 254, 259 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5686
split_0_train_5686
[ { "id": "split_0_train_5686_passage", "type": "progene_text", "text": [ "Molecular misreading of the ubiquitin B gene and hepatic mallory body formation ." ], "offsets": [ [ 0, 81 ] ] } ]
[ { "id": "split_0_train_8766_entity", "type": "progene_text", "text": [ "ubiquitin B" ], "offsets": [ [ 28, 39 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5687
split_0_train_5687
[ { "id": "split_0_train_5687_passage", "type": "progene_text", "text": [ "BACKGROUND & AIMS :" ], "offsets": [ [ 0, 19 ] ] } ]
[]
[]
[]
[]
split_0_train_5688
split_0_train_5688
[ { "id": "split_0_train_5688_passage", "type": "progene_text", "text": [ "Molecular misreading of the ubiquitin B gene has been documented in the cerebral cortex of patients with Alzheimer 's disease and Down syndrome ." ], "offsets": [ [ 0, 145 ] ] } ]
[ { "id": "split_0_train_8767_entity", "type": "progene_text", "text": [ "ubiquitin B" ], "offsets": [ [ 28, 39 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5689
split_0_train_5689
[ { "id": "split_0_train_5689_passage", "type": "progene_text", "text": [ "This novel process consists of the unfaithful conversion of genomic information into aberrant transcripts and its subsequent translation into + 1 proteins ." ], "offsets": [ [ 0, 156 ] ] } ]
[]
[]
[]
[]
split_0_train_5690
split_0_train_5690
[ { "id": "split_0_train_5690_passage", "type": "progene_text", "text": [ "METHODS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_5691
split_0_train_5691
[ { "id": "split_0_train_5691_passage", "type": "progene_text", "text": [ "Because Mallory bodies ( MBs ) also contain ubiquitinated proteins , we stained 11 autopsied and 6 biopsied MB - containing livers from patients with steatohepatitis with an antibody to ubiquitin (+1) to look for the presence of mutant ( ubiquitin (+1) ) protein ." ], "offsets": [ [ 0, 264 ] ] } ]
[ { "id": "split_0_train_8768_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 186, 195 ] ], "normalized": [] }, { "id": "split_0_train_8769_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 238, 247 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5692
split_0_train_5692
[ { "id": "split_0_train_5692_passage", "type": "progene_text", "text": [ "Antibodies to wild - type ubiquitin were used to document the presence of MBs in all cases ." ], "offsets": [ [ 0, 92 ] ] } ]
[ { "id": "split_0_train_8770_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 26, 35 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5693
split_0_train_5693
[ { "id": "split_0_train_5693_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_5694
split_0_train_5694
[ { "id": "split_0_train_5694_passage", "type": "progene_text", "text": [ "Ubiquitin (+1) immunoreactivity was detected in all MB - containing livers with steatohepatitis ; no ubiquitin (+1) immunoreactivity was found in 13 MB - free liver controls ." ], "offsets": [ [ 0, 175 ] ] } ]
[ { "id": "split_0_train_8771_entity", "type": "progene_text", "text": [ "Ubiquitin" ], "offsets": [ [ 0, 9 ] ], "normalized": [] }, { "id": "split_0_train_8772_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 101, 110 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5695
split_0_train_5695
[ { "id": "split_0_train_5695_passage", "type": "progene_text", "text": [ "A subpopulation ( about one third of the MBs ) of the MB - containing hepatocytes in autopsied livers showed ubiquitin ( +1) immunoreactivity ( i.e. , ubiquitin and ubiquitin ( +1) colocalized in MBs ) ." ], "offsets": [ [ 0, 203 ] ] } ]
[ { "id": "split_0_train_8773_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 109, 118 ] ], "normalized": [] }, { "id": "split_0_train_8774_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 151, 160 ] ], "normalized": [] }, { "id": "split_0_train_8775_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 165, 174 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5696
split_0_train_5696
[ { "id": "split_0_train_5696_passage", "type": "progene_text", "text": [ "MB - containing liver biopsy specimens showed colocalization of ubiquitin and ubiquitin (+1) in every MB ." ], "offsets": [ [ 0, 106 ] ] } ]
[ { "id": "split_0_train_8776_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 64, 73 ] ], "normalized": [] }, { "id": "split_0_train_8777_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 78, 87 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5697
split_0_train_5697
[ { "id": "split_0_train_5697_passage", "type": "progene_text", "text": [ "Western blot analysis showed an ubiquitin (+1) band of 11 kilodaltons ." ], "offsets": [ [ 0, 71 ] ] } ]
[ { "id": "split_0_train_8778_entity", "type": "progene_text", "text": [ "ubiquitin" ], "offsets": [ [ 32, 41 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5698
split_0_train_5698
[ { "id": "split_0_train_5698_passage", "type": "progene_text", "text": [ "Molecular misreading of the ubiquitin B gene ( DeltaGU ) was shown in one of the livers , which contained numerous MBs using an expression cloning strategy ." ], "offsets": [ [ 0, 157 ] ] } ]
[ { "id": "split_0_train_8779_entity", "type": "progene_text", "text": [ "ubiquitin B" ], "offsets": [ [ 28, 39 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_5699
split_0_train_5699
[ { "id": "split_0_train_5699_passage", "type": "progene_text", "text": [ "CONCLUSIONS :" ], "offsets": [ [ 0, 13 ] ] } ]
[]
[]
[]
[]